GLYLEZA
Live / Registered — Registered (as of 13 Oct 2020)
What this means for you
Registered since 13 Oct 2020. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §71 affidavit of use is due by 13 Oct 2026, and its filing window is open now).
Record
- Serial number
- 79286201
- Registration number
- 6172128
- Mark type
- Word mark
- Filed
- 24 Apr 2020
- Published for opposition
- 28 Jul 2020
- Registered
- 13 Oct 2020
- Next maintenance filing
- §71 affidavit of use, due by 13 Oct 2026 (grace period to 13 Apr 2027)
Goods and services
- Class 005 — Pharmaceuticals: Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Owner
- Sandoz AG, CH
- NOVARTIS AG, CH
- NOVARTIS AG, CH
- NOVARTIS AG, CH
Prosecution history
- 03 Sept 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 19 Jan 2024 — CHANGE OF OWNER RECEIVED FROM IB
- 25 Dec 2020 — NOTIFICATION PROCESSED BY IB
- 07 Dec 2020 — FINAL DISPOSITION NOTICE SENT TO IB
- 07 Dec 2020 — FINAL DISPOSITION PROCESSED
- 12 Nov 2020 — GRANT OF PROTECTION CREATED, TO BE SENT TO IB
- 13 Oct 2020 — REGISTERED-PRINCIPAL REGISTER
- 31 Jul 2020 — NOTIFICATION PROCESSED BY IB
- 28 Jul 2020 — PUBLISHED FOR OPPOSITION
- 15 Jul 2020 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 15 Jul 2020 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 08 Jul 2020 — NOTICE OF PUBLICATION
- 20 Jun 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Jun 2020 — ASSIGNED TO EXAMINER
- 09 Jun 2020 — APPLICATION FILING RECEIPT MAILED